Intangibles - Summary Of The JMC Intangible Asset (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Net intangible assets | $ 1,417 | $ 883 |
| Journey Medical Corporation [Member] | ||
| Finite-Lived Intangible Assets, Gross | 2,800 | 1,600 |
| Accumulated amortization | 1,383 | 717 |
| Net intangible assets | $ 1,417 | 883 |
| Ceracade [Member] | Journey Medical Corporation [Member] | ||
| Finite-Lived Intangible Asset, Useful Life | 3 years | |
| Finite-Lived Intangible Assets, Gross | $ 300 | 300 |
| Luxamend [Member] | Journey Medical Corporation [Member] | ||
| Finite-Lived Intangible Asset, Useful Life | 3 years | |
| Finite-Lived Intangible Assets, Gross | $ 50 | 50 |
| Targadox [Member] | Journey Medical Corporation [Member] | ||
| Finite-Lived Intangible Asset, Useful Life | 3 years | |
| Finite-Lived Intangible Assets, Gross | $ 1,250 | 1,250 |
| Exelderm [Member] | Journey Medical Corporation [Member] | ||
| Finite-Lived Intangible Asset, Useful Life | 3 years | |
| Finite-Lived Intangible Assets, Gross | $ 1,200 | $ 0 |
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|